Related Experiment Video

Updated: Oct 16, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion

E Liu1, A A Thant, F Kikkawa

  • 1Department of Obstetrics and Gynecology, Nagoya University School of Medicine, Japan.

Cancer Research
|May 16, 2000
PubMed

Insights

The Ras-MEK1 pathway is crucial for matrix metalloproteinase (MMP) secretion and cell invasiveness in v-crk-transformed cells. Inhibiting this pathway significantly reduces MMP secretion and cellular invasion.

Area of Science:

  • Cellular and Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) are key enzymes involved in extracellular matrix degradation.
  • Aberrant MMP secretion is linked to cancer progression and metastasis.
  • The v-crk oncogene transforms cells and promotes invasive behavior.

Purpose of the Study:

  • To elucidate the intracellular signaling pathways regulating MMP secretion in v-crk-transformed cells.
  • To determine the role of the Ras-MEK1 pathway in MMP secretion and cell invasiveness.
  • To investigate the involvement of C3G and c-Jun N-terminal kinase (JNK) in this process.

Main Methods:

  • Utilized dominant-negative Ras (S17N Ras) and MEK1 (MEK1AA) expression in v-crk-transformed 3Y1 cells.
  • Administered pharmacological inhibitors: manumycin A (Ras farnesyltransferase inhibitor) and U0126 (MEK1 inhibitor).
  • Assessed MMP-2 and MMP-9 secretion levels and in vitro cell invasiveness.

Main Results:

  • Expression of S17N Ras or MEK1AA significantly suppressed MMP-2 and MMP-9 secretion.
  • Manumycin A and U0126 inhibited MMP secretion in a dose-dependent manner.
  • Inhibition of the Ras-MEK1 pathway correlated with reduced cellular invasiveness, while C3G-JNK pathway inhibition did not affect MMP secretion.

Conclusions:

  • The Ras-MEK1 signaling pathway is a critical regulator of MMP secretion and invasiveness in v-crk-transformed cells.
  • The C3G-JNK pathway does not appear to play a significant role in MMP secretion in this model.
  • Targeting the Ras-MEK1 pathway may offer a therapeutic strategy to inhibit cancer cell invasion.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...